Blog

Apr 26, 2024

CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing

Posted by in category: biotech/medical

Cas9 nucleases hold clinical significance for genome editing therapies. Here the authors characterize CoCas9, a compact, efficient and precise Cas9 from the human microbiome, and show that delivery via AAV vectors enables efficient editing in the mouse retina, expanding the genome editing toolbox.

Comments are closed.